{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T18:27:59Z","timestamp":1793384879347,"version":"4.5.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,29]],"date-time":"2024-01-29T00:00:00Z","timestamp":1706486400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,29]],"date-time":"2024-01-29T00:00:00Z","timestamp":1706486400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["F31AI164846"],"award-info":[{"award-number":["F31AI164846"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["U19AI129326"],"award-info":[{"award-number":["U19AI129326"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["U19AI129326"],"award-info":[{"award-number":["U19AI129326"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["U19AI129326"],"award-info":[{"award-number":["U19AI129326"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["U19AI129326"],"award-info":[{"award-number":["U19AI129326"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["U19AI129326"],"award-info":[{"award-number":["U19AI129326"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000061","name":"Fogarty International Center","doi-asserted-by":"publisher","award":["D43TW001505"],"award-info":[{"award-number":["D43TW001505"]}],"id":[{"id":"10.13039\/100000061","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000061","name":"Fogarty International Center","doi-asserted-by":"publisher","award":["D43TW001505"],"award-info":[{"award-number":["D43TW001505"]}],"id":[{"id":"10.13039\/100000061","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000061","name":"Fogarty International Center","doi-asserted-by":"publisher","award":["D43TW001505"],"award-info":[{"award-number":["D43TW001505"]}],"id":[{"id":"10.13039\/100000061","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Timely molecular surveillance of\n                      <jats:italic>Plasmodium falciparum kelch 13<\/jats:italic>\n                      (\n                      <jats:italic>k13<\/jats:italic>\n                      ) gene mutations is essential for monitoring the emergence and stemming the spread of artemisinin resistance. Widespread artemisinin resistance, as observed in Southeast Asia, would reverse significant gains that have been made against the malaria burden in Africa. The purpose of this study was to assess the prevalence of\n                      <jats:italic>k13<\/jats:italic>\n                      polymorphisms in western Kenya and Ethiopia at sites representing varying transmission intensities between 2018 and 2022.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Dried blood spot samples collected through ongoing passive surveillance and malaria epidemiological studies, respectively, were investigated. The\n                      <jats:italic>k13<\/jats:italic>\n                      gene was genotyped in\n                      <jats:italic>P. falciparum<\/jats:italic>\n                      isolates with high parasitaemia: 775 isolates from four sites in western Kenya (Homa Bay, Kakamega, Kisii, and Kombewa) and 319 isolates from five sites across Ethiopia (Arjo, Awash, Gambella, Dire Dawa, and Semera). DNA sequence variation and neutrality were analysed within each study site where mutant alleles were detected.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Sixteen Kelch13 haplotypes were detected in this study. Prevalence of nonsynonymous\n                      <jats:italic>k13<\/jats:italic>\n                      mutations was low in both western Kenya (25\/783, 3.19%) and Ethiopia (5\/319, 1.57%) across the study period. Two WHO-validated mutations were detected: A675V in three isolates from Kenya and R622I in four isolates from Ethiopia. Seventeen samples from Kenya carried synonymous mutations (2.17%). No synonymous mutations were detected in Ethiopia. Genetic variation analyses and tests of neutrality further suggest an excess of low frequency polymorphisms in each study site. Fu and Li\u2019s F test statistic in Semera was 0.48 (P\u2009&gt;\u20090.05), suggesting potential population selection of R622I, which appeared at a relatively high frequency (3\/22, 13.04%).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      This study presents an updated report on the low frequency of\n                      <jats:italic>k13<\/jats:italic>\n                      mutations in western Kenya and Ethiopia. The WHO-validated R622I mutation, which has previously only been reported along the north-west border of Ethiopia, appeared in four isolates collected from eastern Ethiopia. The rapid expansion of R622I across Ethiopia signals the need for enhanced monitoring of the spread of drug-resistant\n                      <jats:italic>P. falciparum<\/jats:italic>\n                      parasites in East Africa. Although ACT remains currently efficacious in the study areas, continued surveillance is necessary to detect early indicators of artemisinin partial resistance.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12936-023-04812-y","type":"journal-article","created":{"date-parts":[[2024,1,29]],"date-time":"2024-01-29T03:02:53Z","timestamp":1706497373000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["Molecular surveillance of Kelch 13 polymorphisms in Plasmodium falciparum isolates from Kenya and Ethiopia"],"prefix":"10.1186","volume":"23","author":[{"given":"Brook","family":"Jeang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daibin","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Chieh","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harrysone","family":"Atieli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delenasaw","family":"Yewhalaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guiyun","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,29]]},"reference":[{"key":"4812_CR1","doi-asserted-by":"crossref","unstructured":"Phyo AP, Nosten F, Phyo AP, Nosten F. The Artemisinin Resistance in Southeast Asia: An Imminent Global Threat to Malaria Elimination. In: Manguin S, Dev V (eds.); Towards Malaria Elimination - A Leap Forward. IntechOpen; 2018 [cited 2023 Jul 12]. https:\/\/www.intechopen.com\/chapters\/60988","DOI":"10.5772\/intechopen.76519"},{"key":"4812_CR2","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1186\/1475-2875-13-452","volume":"13","author":"Y Lubell","year":"2014","unstructured":"Lubell Y, Dondorp A, Gu\u00e9rin PJ, Drake T, Meek S, Ashley E, et al. Artemisinin resistance\u2014modelling the potential human and economic costs. Malar J. 2014;13:452.","journal-title":"Malar J"},{"key":"4812_CR3","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/nature12876","volume":"505","author":"F Ariey","year":"2014","unstructured":"Ariey F, Witkowski B, Amaratunga C, Beghain J, Langlois A-C, Khim N, et al. A molecular marker of artemisinin-resistant Plasmodium falciparum malaria. Nature. 2014;505:50\u20135.","journal-title":"Nature"},{"key":"4812_CR4","unstructured":"Global Malaria Programme. Artemisinin and artemisinin-based combination therapy resistance, April 2017. World Health Organization; 2017 Apr https:\/\/iris.who.int\/bitstream\/handle\/10665\/255213\/WHO-HTM-GMP-2017.9-eng.pdf?sequence=1."},{"key":"4812_CR5","doi-asserted-by":"publisher","first-page":"2453","DOI":"10.1056\/NEJMoa1513137","volume":"374","author":"D M\u00e9nard","year":"2016","unstructured":"M\u00e9nard D, Khim N, Beghain J, Adegnika AA, Shafiul-Alam M, Amodu O, et al. A worldwide map of Plasmodium falciparum K13-propeller polymorphisms. N Engl J Med. 2016;374:2453\u201364.","journal-title":"N Engl J Med"},{"key":"4812_CR6","volume-title":"World malaria report 2022","author":"WHO","year":"2022","unstructured":"WHO. World malaria report 2022. Geneva: World Health Organization; 2022."},{"key":"4812_CR7","doi-asserted-by":"publisher","first-page":"e82","DOI":"10.1016\/S1473-3099(20)30493-X","volume":"21","author":"NK Kayiba","year":"2021","unstructured":"Kayiba NK, Yobi DM, Tshibangu-Kabamba E, Tuan VP, Yamaoka Y, Devleesschauwer B, et al. Spatial and molecular mapping of Pfkelch13 gene polymorphism in Africa in the era of emerging Plasmodium falciparum resistance to artemisinin: a systematic review. Lancet Infect Dis. 2021;21:e82-92.","journal-title":"Lancet Infect Dis"},{"key":"4812_CR8","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1056\/NEJMoa2101746","volume":"385","author":"B Balikagala","year":"2021","unstructured":"Balikagala B, Fukuda N, Ikeda M, Katuro OT, Tachibana SI, Yamauchi M, et al. Evidence of artemisinin-resistant malaria in Africa. N Engl J Med. 2021;385:1163\u201371.","journal-title":"N Engl J Med"},{"key":"4812_CR9","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1016\/S1473-3099(21)00142-0","volume":"21","author":"A Uwimana","year":"2021","unstructured":"Uwimana A, Umulisa N, Venkatesan M, Svigel SS, Zhou Z, Munyaneza T, et al. Association of Plasmodium falciparum kelch13 R561H genotypes with delayed parasite clearance in Rwanda: an open-label, single-arm, multicentre, therapeutic efficacy study. Lancet Infect Dis. 2021;21:1120\u20138.","journal-title":"Lancet Infect Dis"},{"key":"4812_CR10","doi-asserted-by":"publisher","first-page":"3500","DOI":"10.1038\/s41598-020-60549-7","volume":"10","author":"GM Bwire","year":"2020","unstructured":"Bwire GM, Ngasala B, Mikomangwa WP, Kilonzi M, Kamuhabwa AAR. Detection of mutations associated with artemisinin resistance at k13-propeller gene and a near complete return of chloroquine susceptible falciparum malaria in Southeast of Tanzania. Sci Rep. 2020;10:3500.","journal-title":"Sci Rep"},{"key":"4812_CR11","unstructured":"National strategic plan for malaria prevention control and elimination in Ethiopia 2011\u20132015. Addis Ababa, Ethiopia; 2010 [cited 2023 Jul 13]. https:\/\/www.nationalplanningcycles.org\/sites\/default\/files\/country_docs\/Ethiopia\/ethiopia_malaria_national_strategic_plan_2011-2015_130810.pdf"},{"key":"4812_CR12","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/1475-2875-6-72","volume":"6","author":"AA Amin","year":"2007","unstructured":"Amin AA, Zurovac D, Kangwana BB, Greenfield J, Otieno DN, Akhwale WS, et al. The challenges of changing national malaria drug policy to artemisinin-based combinations in Kenya. Malar J. 2007;6:72.","journal-title":"Malar J"},{"key":"4812_CR13","doi-asserted-by":"publisher","first-page":"490","DOI":"10.3201\/eid2103.140898","volume":"21","author":"R Isozumi","year":"2015","unstructured":"Isozumi R, Uemura H, Kimata I, Ichinose Y, Logedi J, Omar AH, et al. Novel mutations in K13 propeller gene of artemisinin-resistant Plasmodium falciparum. Emerg Infect Dis. 2015;21:490\u20132.","journal-title":"Emerg Infect Dis"},{"key":"4812_CR14","doi-asserted-by":"publisher","first-page":"e01067","DOI":"10.1128\/AAC.01067-19","volume":"63","author":"K Wamae","year":"2019","unstructured":"Wamae K, Okanda D, Ndwiga L, Osoti V, Kimenyi KM, Abdi AI, et al. No Evidence of Plasmodium falciparum k13 artemisinin resistance-conferring mutations over a 24-year analysis in Coastal Kenya but a near complete reversion to chloroquine-sensitive parasites. Antimicrob Agents Chemother. 2019;63:e01067-e1119.","journal-title":"Antimicrob Agents Chemother"},{"key":"4812_CR15","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.4269\/ajtmh.17-0505","volume":"98","author":"ZR de Laurent","year":"2018","unstructured":"de Laurent ZR, Chebon LJ, Ingasia LA, Akala HM, Andagalu B, Ochola-Oyier LI, et al. Polymorphisms in the K13 gene in Plasmodium falciparum from different malaria transmission areas of Kenya. Am J Trop Med Hyg. 2018;98:1360\u20136.","journal-title":"Am J Trop Med Hyg"},{"key":"4812_CR16","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s12936-023-04517-2","volume":"22","author":"JN Maniga","year":"2023","unstructured":"Maniga JN, Samuel M, John O, Rael M, Muchiri JN, Bwogo P, et al. Novel Plasmodium falciparum k13 gene polymorphisms from Kisii County, Kenya during an era of artemisinin-based combination therapy deployment. Malar J. 2023;22:87.","journal-title":"Malar J"},{"key":"4812_CR17","doi-asserted-by":"publisher","first-page":"7540","DOI":"10.1128\/AAC.01894-15","volume":"59","author":"NW Lucchi","year":"2015","unstructured":"Lucchi NW, Komino F, Okoth SA, Goldman I, Onyona P, Wiegand RE, et al. In vitro and molecular surveillance for antimalarial drug resistance in Plasmodium falciparum parasites in Western Kenya reveals sustained artemisinin sensitivity and increased chloroquine sensitivity. Antimicrob Agents Chemother. 2015;59:7540\u20137.","journal-title":"Antimicrob Agents Chemother"},{"key":"4812_CR18","doi-asserted-by":"publisher","first-page":"132","DOI":"10.4269\/ajtmh.15-0477","volume":"94","author":"AG Bayih","year":"2016","unstructured":"Bayih AG, Getnet G, Alemu A, Getie S, Mohon AN, Pillai DR. A unique plasmodium falciparum Kelch 13 gene mutation in Northwest Ethiopia. Am J Trop Med Hyg. 2016;94:132\u20135.","journal-title":"Am J Trop Med Hyg"},{"key":"4812_CR19","doi-asserted-by":"publisher","first-page":"0005806","DOI":"10.1371\/journal.pntd.0005806","volume":"11","author":"E Lo","year":"2017","unstructured":"Lo E, Hemming-Schroeder E, Yewhalaw D, Nguyen J, Kebede E, Zemene E, et al. Transmission dynamics of co-endemic Plasmodium vivax and P. falciparum in Ethiopia and prevalence of antimalarial resistant genotypes. PLoS Negl Trop Dis. 2017;11:0005806.","journal-title":"PLoS Negl Trop Dis"},{"key":"4812_CR20","first-page":"1352","volume":"211","author":"E Kamau","year":"2015","unstructured":"Kamau E, Campino S, Amenga-Etego L, Drury E, Ishengoma D, Johnson K, et al. K13-propeller polymorphisms in Plasmodium falciparum parasites from sub-Saharan Africa. J Infect Dis. 2015;211:1352\u20135.","journal-title":"J Infect Dis"},{"key":"4812_CR21","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.4269\/ajtmh.19-0142","volume":"101","author":"NF Brazeau","year":"2019","unstructured":"Brazeau NF, Assefa A, Mohammed H, Seme H, Tsadik AG, Parr JB, et al. Pooled deep sequencing of drug resistance loci from Plasmodium falciparum parasites across Ethiopia. Am J Trop Med Hyg. 2019;101:1139\u201343.","journal-title":"Am J Trop Med Hyg"},{"key":"4812_CR22","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1186\/s12936-022-04288-2","volume":"21","author":"CJ Omondi","year":"2022","unstructured":"Omondi CJ, Otambo WO, Odongo D, Ochwedo KO, Otieno A, Onyango SA, et al. Asymptomatic and submicroscopic Plasmodium infections in an area before and during integrated vector control in Homa Bay, western Kenya. Malar J. 2022;21:272.","journal-title":"Malar J"},{"key":"4812_CR23","unstructured":"National Malaria Control Programme. Kenya Malaria Strategy 2019\u20132023. Nairobi, Kenya: Ministry of Health; [cited 2020 Oct 23]. http:\/\/fountainafrica.org\/wp-content\/uploads\/2020\/01\/Kenya-Malaria-Strategy-2019-2023.pdf"},{"key":"4812_CR24","unstructured":"Federal Ministry of Health. Ethiopia Malaria Elimination Strategic Plan: 2021\u20132025. Addis Ababa, Ethiopia: 2020."},{"key":"4812_CR25","unstructured":"The World Bank Group. Climate risk country profile: Ethiopia [Internet]. Washington DC, USA: 2021 [cited 2023 Jul 17]. https:\/\/climateknowledgeportal.worldbank.org\/sites\/default\/files\/2021-05\/15463A-WB_Ethiopia%20Country%20Profile-WEB.pdf"},{"key":"4812_CR26","doi-asserted-by":"publisher","first-page":"249","DOI":"10.4269\/ajtmh.2005.72.249","volume":"72","author":"S Bereczky","year":"2005","unstructured":"Bereczky S, M\u00e5rtensson A, Gil JP, F\u00e4rnert A. Rapid DNA extraction from archive blood spots on filter paper for genotyping of Plasmodium falciparum. Am J Trop Med Hyg. 2005;72:249\u201351.","journal-title":"Am J Trop Med Hyg"},{"key":"4812_CR27","doi-asserted-by":"publisher","first-page":"16139","DOI":"10.1038\/s41598-020-73073-5","volume":"10","author":"D Zhong","year":"2020","unstructured":"Zhong D, Hemming-Schroeder E, Wang X, Kibret S, Zhou G, Atieli H, et al. Extensive new Anopheles cryptic species involved in human malaria transmission in western Kenya. Sci Rep. 2020;10:16139.","journal-title":"Sci Rep"},{"key":"4812_CR28","first-page":"95","volume":"41","author":"TA Hall","year":"1999","unstructured":"Hall TA. BioEdit\u202f: a user-friendly biological sequence alignment editor and analysis program for Windows 95\/98\/NT. Nucleic Acids Symp Ser. 1999;41:95\u20138.","journal-title":"Nucleic Acids Symp Ser"},{"key":"4812_CR29","doi-asserted-by":"publisher","first-page":"3299","DOI":"10.1093\/molbev\/msx248","volume":"34","author":"J Rozas","year":"2017","unstructured":"Rozas J, Ferrer-Mata A, S\u00e1nchez-DelBarrio JC, Guirao-Rico S, Librado P, Ramos-Onsins SE, et al. DnaSP 6: DNA Sequence polymorphism analysis of large data sets. Mol Biol Evol. 2017;34:3299\u2013302.","journal-title":"Mol Biol Evol"},{"key":"4812_CR30","doi-asserted-by":"publisher","first-page":"692","DOI":"10.4269\/ajtmh.17-0763","volume":"98","author":"E Hemming-Schroeder","year":"2018","unstructured":"Hemming-Schroeder E, Umukoro E, Lo E, Fung B, Tom\u00e1s-Domingo P, Zhou G, et al. Impacts of antimalarial drugs on Plasmodium falciparum drug resistance markers, Western Kenya, 2003\u20132015. Am J Trop Med Hyg. 2018;98:692\u20139.","journal-title":"Am J Trop Med Hyg"},{"key":"4812_CR31","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1186\/s12936-015-0723-2","volume":"14","author":"A Heuchert","year":"2015","unstructured":"Heuchert A, Abduselam N, Zeynudin A, Eshetu T, L\u00f6scher T, Wieser A, et al. Molecular markers of anti-malarial drug resistance in southwest Ethiopia over time: regional surveillance from 2006 to 2013. Malar J. 2015;14:208.","journal-title":"Malar J"},{"key":"4812_CR32","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1093\/infdis\/jiu467","volume":"211","author":"SM Taylor","year":"2015","unstructured":"Taylor SM, Parobek CM, DeConti DK, Kayentao K, Coulibaly SO, Greenwood BM, et al. Absence of putative artemisinin resistance mutations among Plasmodium falciparum in sub-Saharan Africa: a molecular epidemiologic study. J Infect Dis. 2015;211:680\u20138.","journal-title":"J Infect Dis"},{"key":"4812_CR33","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.ijpddr.2021.06.001","volume":"16","author":"L Ndwiga","year":"2021","unstructured":"Ndwiga L, Kimenyi KM, Wamae K, Osoti V, Akinyi M, Omedo I, et al. A review of the frequencies of Plasmodium falciparum Kelch 13 artemisinin resistance mutations in Africa. Int J Parasitol Drugs Drug Resist. 2021;16:155\u201361.","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"4812_CR34","doi-asserted-by":"publisher","first-page":"45","DOI":"10.12688\/wellcomeopenres.17656.1","volume":"7","author":"I Omedo","year":"2022","unstructured":"Omedo I, Bartilol B, Kimani D, Gon\u00e7alves S, Drury E, Rono MK, et al. Spatio-temporal distribution of antimalarial drug resistant gene mutations in a Plasmodium falciparum parasite population from Kilifi, Kenya: a 25-year retrospective study. Wellcome Open Res. 2022;7:45.","journal-title":"Wellcome Open Res"},{"key":"4812_CR35","doi-asserted-by":"publisher","first-page":"e184","DOI":"10.1016\/S2666-5247(21)00249-4","volume":"3","author":"FM Kagoro","year":"2022","unstructured":"Kagoro FM, Barnes KI, Marsh K, Ekapirat N, Mercado CEG, Sinha I, et al. Mapping genetic markers of artemisinin resistance in Plasmodium falciparum malaria in Asia: a systematic review and spatiotemporal analysis. Lancet Microbe. 2022;3:e184\u201392.","journal-title":"Lancet Microbe"},{"key":"4812_CR36","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.actatropica.2018.06.016","volume":"185","author":"SJ Smith","year":"2018","unstructured":"Smith SJ, Kamara ARY, Sahr F, Samai M, Swaray AS, Menard D, et al. Efficacy of artemisinin-based combination therapies and prevalence of molecular markers associated with artemisinin, piperaquine and sulfadoxine-pyrimethamine resistance in Sierra Leone. Acta Trop. 2018;185:363\u201370.","journal-title":"Acta Trop"},{"key":"4812_CR37","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1093\/infdis\/jiab352","volume":"225","author":"J Straimer","year":"2021","unstructured":"Straimer J, Gandhi P, Renner KC, Schmitt EK. High prevalence of Plasmodium falciparum K13 mutations in Rwanda is associated with slow parasite clearance after treatment with artemether-lumefantrine. J Infect Dis. 2021;225:1411\u20134.","journal-title":"J Infect Dis"},{"key":"4812_CR38","volume-title":"Report on antimalarial drug efficacy, resistance and response: 10 years of surveillance (2010\u20132019)","author":"WHO","year":"2020","unstructured":"WHO. Report on antimalarial drug efficacy, resistance and response: 10 years of surveillance (2010\u20132019). Geneva: World Health Organization; 2020."},{"key":"4812_CR39","doi-asserted-by":"crossref","unstructured":"Alemayehu AA, Castaneda-Mogollon D, Tesfa H, Getie S, Mohon AN, Balasingam N, et al. Expansion of the Plasmodium falciparum Kelch 13 R622I mutation in Northwest Ethiopia [Internet]. Res Square. 2021. https:\/\/www.researchsquare.com\/article\/rs-171038\/v1","DOI":"10.21203\/rs.3.rs-171038\/v1"},{"key":"4812_CR40","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1038\/s41564-023-01461-4","volume":"8","author":"AA Fola","year":"2023","unstructured":"Fola AA, Feleke SM, Mohammed H, Brhane BG, Hennelly CM, Assefa A, et al. Plasmodium falciparum resistant to artemisinin and diagnostics have emerged in Ethiopia. Nat Microbiol. 2023;8:1911\u20139.","journal-title":"Nat Microbiol"},{"key":"4812_CR41","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s12936-020-3140-0","volume":"19","author":"X Wang","year":"2020","unstructured":"Wang X, Ruan W, Zhou S, Huang F, Lu Q, Feng X, et al. Molecular surveillance of Pfcrt and k13 propeller polymorphisms of imported Plasmodium falciparum cases to Zhejiang Province, China between 2016 and 2018. Malar J. 2020;19:59.","journal-title":"Malar J"},{"key":"4812_CR42","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.4269\/ajtmh.17-0364","volume":"97","author":"Z Pava","year":"2017","unstructured":"Pava Z, Handayuni I, Trianty L, Utami RAS, Tirta YK, Puspitasari AM, et al. Passively versus actively detected malaria: similar genetic diversity but different complexity of infection. Am J Trop Med Hyg. 2017;97:1788\u201396.","journal-title":"Am J Trop Med Hyg"},{"key":"4812_CR43","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1186\/s12936-016-1487-z","volume":"15","author":"G Falq","year":"2016","unstructured":"Falq G, Van Den Bergh R, De Smet M, Etienne W, Nguon C, Rekol H, et al. Assessing the asymptomatic reservoir and dihydroartemisinin\u2013piperaquine effectiveness in a low transmission setting threatened by artemisinin resistant Plasmodium falciparum. Malar J. 2016;15:446.","journal-title":"Malar J"},{"key":"4812_CR44","doi-asserted-by":"publisher","first-page":"e01945","DOI":"10.1128\/aac.01945-21","volume":"66","author":"V Osoti","year":"2022","unstructured":"Osoti V, Akinyi M, Wamae K, Kimenyi KM, de Laurent Z, Ndwiga L, et al. Targeted amplicon deep sequencing for monitoring antimalarial resistance markers in Western Kenya. Antimicrob Agents Chemother. 2022;66:e01945-e2021.","journal-title":"Antimicrob Agents Chemother"},{"key":"4812_CR45","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1186\/s12936-020-03454-8","volume":"19","author":"MA Pacheco","year":"2020","unstructured":"Pacheco MA, Schneider KA, Cheng Q, Munde EO, Ndege C, Onyango C, et al. Changes in the frequencies of Plasmodium falciparum dhps and dhfr drug-resistant mutations in children from Western Kenya from 2005 to 2018: the rise of Pfdhps S436H. Malar J. 2020;19:378.","journal-title":"Malar J"},{"key":"4812_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.meegid.2019.104121","volume":"78","author":"KB Musyoka","year":"2020","unstructured":"Musyoka KB, Kiiru JN, Aluvaala E, Omondi P, Chege WK, Judah T, et al. Prevalence of mutations in Plasmodium falciparum genes associated with resistance to different antimalarial drugs in Nyando, Kisumu County in Kenya. Infect Genet Evol. 2020;78: 104121.","journal-title":"Infect Genet Evol"},{"key":"4812_CR47","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1186\/s12936-016-1587-9","volume":"15","author":"JE Coalson","year":"2016","unstructured":"Coalson JE, Walldorf JA, Cohee LM, Ismail MD, Mathanga D, Cordy RJ, et al. High prevalence of Plasmodium falciparum gametocyte infections in school-age children using molecular detection: patterns and predictors of risk from a cross-sectional study in southern Malawi. Malar J. 2016;15:527.","journal-title":"Malar J"},{"key":"4812_CR48","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1186\/s12936-019-2876-x","volume":"18","author":"IM Bashir","year":"2019","unstructured":"Bashir IM, Nyakoe N, van der Sande M. Targeting remaining pockets of malaria transmission in Kenya to hasten progress towards national elimination goals: an assessment of prevalence and risk factors in children from the Lake endemic region. Malar J. 2019;18:233.","journal-title":"Malar J"},{"key":"4812_CR49","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1093\/infdis\/jiac169","volume":"226","author":"J Rek","year":"2022","unstructured":"Rek J, Blanken SL, Okoth J, Ayo D, Onyige I, Musasizi E, et al. Asymptomatic school-aged children are important drivers of malaria transmission in a high endemicity setting in Uganda. J Infect Dis. 2022;226:708\u201313.","journal-title":"J Infect Dis"},{"key":"4812_CR50","first-page":"5924","volume":"10","author":"AO Touray","year":"2020","unstructured":"Touray AO, Mobegi VA, Wamunyokoli F, Herren JK. Diversity and multiplicity of P. falciparum infections among asymptomatic school children in Mbita. Western Kenya Sci Rep. 2020;10:5924.","journal-title":"Western Kenya. Sci Rep."},{"key":"4812_CR51","doi-asserted-by":"publisher","first-page":"e01163","DOI":"10.1128\/AAC.01163-21","volume":"66","author":"M Kanai","year":"2022","unstructured":"Kanai M, Yeo T, Asua V, Rosenthal PJ, Fidock DA, Mok S. Comparative analysis of Plasmodium falciparum genotyping via SNP detection, microsatellite profiling, and whole-genome sequencing. Antimicrob Agents Chemother. 2022;66:e01163-e1221.","journal-title":"Antimicrob Agents Chemother"},{"key":"4812_CR52","doi-asserted-by":"publisher","first-page":"e1003318","DOI":"10.1371\/journal.pmed.1003318","volume":"17","author":"MA Hartley","year":"2020","unstructured":"Hartley MA, Hofmann N, Keitel K, Kagoro F, Moniz CA, Mlaganile T, et al. Clinical relevance of low-density Plasmodium falciparum parasitemia in untreated febrile children: a cohort study. PLoS Med. 2020;17:e1003318.","journal-title":"PLoS Med"}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-023-04812-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12936-023-04812-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-023-04812-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,29]],"date-time":"2024-01-29T15:04:30Z","timestamp":1706540670000},"score":1,"resource":{"primary":{"URL":"https:\/\/malariajournal.biomedcentral.com\/articles\/10.1186\/s12936-023-04812-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,29]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["4812"],"URL":"https:\/\/doi.org\/10.1186\/s12936-023-04812-y","relation":{},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,29]]},"assertion":[{"value":"29 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was obtained from the institutional review boards of the University of California, Irvine; Maseno University, Kenya; and Jimma University Institute of Health, Ethiopia. For all studies, approval was first received from the division offices of the Ministry of Health. Written informed consent\/ assent was then obtained from all consenting heads of households and for everyone who was willing to participate. All dried blood spot samples were de-identified. For schoolchildren dynamics studies, permission was received from school administrators. Assent was obtained from all students who were willing to participate in the surveys. Individuals who were unwilling to participate were excluded from all studies. Participants harbouring asymptomatic infections were not treated with antimalarials. Symptomatic volunteers were referred to local health facilities for diagnosis and treatment free of charge, in accordance with national policies.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"36"}}